Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Intangibles (2019 - 2025)

IGC Pharma (IGC) has disclosed Change in Intangibles for 7 consecutive years, with $297000.0 as the latest value for Q3 2025.

  • Quarterly Change in Intangibles rose 471.15% to $297000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $636000.0 through Sep 2025, up 34.18% year-over-year, with the annual reading at $370000.0 for FY2025, 1.86% down from the prior year.
  • Change in Intangibles for Q3 2025 was $297000.0 at IGC Pharma, up from $114000.0 in the prior quarter.
  • The five-year high for Change in Intangibles was $498000.0 in Q1 2022, with the low at $2000.0 in Q2 2021.
  • Average Change in Intangibles over 5 years is $106947.4, with a median of $52000.0 recorded in 2024.
  • The sharpest move saw Change in Intangibles plummeted 92.31% in 2021, then skyrocketed 1560.0% in 2022.
  • Over 5 years, Change in Intangibles stood at $22000.0 in 2021, then soared by 281.82% to $84000.0 in 2022, then plummeted by 77.38% to $19000.0 in 2023, then soared by 305.26% to $77000.0 in 2024, then surged by 285.71% to $297000.0 in 2025.
  • According to Business Quant data, Change in Intangibles over the past three periods came in at $297000.0, $114000.0, and $148000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.